These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gene therapy in rheumatic diseases. Vervoordeldonk MJ; Tak PP Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):771-88. PubMed ID: 11812021 [TBL] [Abstract][Full Text] [Related]
5. Developing the concept of adoptive cellular gene therapy of rheumatoid arthritis. Tarner IH; Neumann E; Gay S; Fathman CG; Müller-Ladner U Autoimmun Rev; 2006 Feb; 5(2):148-52. PubMed ID: 16431349 [TBL] [Abstract][Full Text] [Related]
6. Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Wright GP; Notley CA; Xue SA; Bendle GM; Holler A; Schumacher TN; Ehrenstein MR; Stauss HJ Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19078-83. PubMed ID: 19884493 [TBL] [Abstract][Full Text] [Related]
7. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis. Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921 [TBL] [Abstract][Full Text] [Related]
8. Treatment of autoimmune disease by adoptive cellular gene therapy. Tarner IH; Slavin AJ; McBride J; Levicnik A; Smith R; Nolan GP; Contag CH; Fathman CG Ann N Y Acad Sci; 2003 Sep; 998():512-9. PubMed ID: 14592922 [TBL] [Abstract][Full Text] [Related]
9. Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4. Tarner IH; Nakajima A; Seroogy CM; Ermann J; Levicnik A; Contag CH; Fathman CG Clin Immunol; 2002 Dec; 105(3):304-14. PubMed ID: 12498812 [TBL] [Abstract][Full Text] [Related]
10. Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients? van de Loo FA; Smeets RL; van den Berg WB Arthritis Res Ther; 2004; 6(5):183-96. PubMed ID: 15380032 [TBL] [Abstract][Full Text] [Related]
11. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663 [TBL] [Abstract][Full Text] [Related]
12. Gene therapy as a therapeutic approach for the treatment of rheumatoid arthritis: innovative vectors and therapeutic genes. Adriaansen J; Vervoordeldonk MJ; Tak PP Rheumatology (Oxford); 2006 Jun; 45(6):656-68. PubMed ID: 16510530 [TBL] [Abstract][Full Text] [Related]
13. Systemic lentivirus-mediated delivery of short hairpin RNA targeting calcium release-activated calcium channel 3 as gene therapy for collagen-induced arthritis. Liu S; Kiyoi T; Takemasa E; Maeyama K J Immunol; 2015 Jan; 194(1):76-83. PubMed ID: 25422506 [TBL] [Abstract][Full Text] [Related]
14. Recent developments in molecular therapeutic approaches for rheumatoid arthritis. Woods A; Hobson P; Klavinskis LS Curr Opin Mol Ther; 2004 Aug; 6(4):395-402. PubMed ID: 15468598 [TBL] [Abstract][Full Text] [Related]
19. The SCID mouse model: novel therapeutic targets - lessons from gene transfer. Pierer M; Müller-Ladner U; Pap T; Neidhart M; Gay RE; Gay S Springer Semin Immunopathol; 2003 Aug; 25(1):65-78. PubMed ID: 12904892 [TBL] [Abstract][Full Text] [Related]
20. Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints. Angyal A; Egelston C; Kobezda T; Olasz K; László A; Glant TT; Mikecz K Arthritis Res Ther; 2010; 12(2):R44. PubMed ID: 20298547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]